ACCUMED INTERNATIONAL INC
10-Q, EX-27.1, 2000-08-10
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: ACCUMED INTERNATIONAL INC, 10-Q, EX-10.1, 2000-08-10
Next: OMEGA HEALTHCARE INVESTORS INC, 4, 2000-08-10



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                             656
<SECURITIES>                                       237
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                        692
<CURRENT-ASSETS>                                 1,626
<PP&E>                                           2,068
<DEPRECIATION>                                   1,507
<TOTAL-ASSETS>                                   6,899
<CURRENT-LIABILITIES>                            1,614
<BONDS>                                            405
                               57
                                          0
<COMMON>                                         2,868
<OTHER-SE>                                       1,152
<TOTAL-LIABILITY-AND-EQUITY>                     6,899
<SALES>                                            168
<TOTAL-REVENUES>                                   239
<CGS>                                               50
<TOTAL-COSTS>                                       50
<OTHER-EXPENSES>                                 2,241
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  15
<INCOME-PRETAX>                                (1,711)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (1,711)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,711)
<EPS-BASIC>                                      (.31)
<EPS-DILUTED>                                    (.31)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission